Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Suzhou Fengbei Biotech Stock Co's Revenue for the
three
months ended in Jun. 2026 was ¥1,238 Mil. Suzhou Fengbei Biotech Stock Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was ¥262 Mil.
Hence, Suzhou Fengbei Biotech Stock Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 4.72.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Suzhou Fengbei Biotech Stock Co Receivables Turnover Related Terms
Suzhou Fengbei Biotech Stock Co Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co Receivables Turnover Chart
SHSE:603334 vs WM, RSG, WCN: Receivables Turnover Comparison
For the Waste Management subindustry, Suzhou Fengbei Biotech Stock Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Fengbei Biotech Stock Co Receivables Turnover vs Waste Management Industry
For the Waste Management industry and Industrials sector, Suzhou Fengbei Biotech Stock Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Suzhou Fengbei Biotech Stock Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Receivables Turnover of 4.72 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. According to the industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #8 out of 237 companies in the Waste Management industry, placing it in the top 3.4%.
Is Suzhou Fengbei Biotech Stock Co's Receivables Turnover too high?
Suzhou Fengbei Biotech Stock Co's current Receivables Turnover is 4.72. The Waste Management industry median Receivables Turnover is 4.86. Suzhou Fengbei Biotech Stock Co's value of 4.72 is 2.9% below this industry median. Based on the distribution chart, Suzhou Fengbei Biotech Stock Co ranks #8 out of 237 companies in the Waste Management industry, which is in the top quartile — a strong position relative to peers. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Receivables Turnover compare to WM and RSG?
According to the Waste Management industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #8 out of 237 companies for Receivables Turnover. This places Suzhou Fengbei Biotech Stock Co in the top 3% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 4.86. Suzhou Fengbei Biotech Stock Co's value of 4.72 is 2.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Waste Management company?
The median Receivables Turnover among Waste Management companies is 4.86, based on 237 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Fengbei Biotech Stock Co's current Receivables Turnover of 4.72 is 2.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. For the Waste Management industry, the median Receivables Turnover is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Fengbei Biotech Stock Co's current Receivables Turnover is 4.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Receivables Turnover of 4.72. The current Receivables Turnover is 4.72 and 2.9% below the Waste Management industry median of 4.86. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Receivables Turnover is 4.72 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
44GF Score
Get the complete analysis for SHSE:603334
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603334 has been successfully added to your 
